ESG Trends in the Healthcare Industry
Report Scope:
The report scope includes healthcare equipment and services providers, biotechnology companies, and life sciences tools and services companies. The report excludes the pharmaceutical industry. The report will have a detailed analysis of key opportunities that would help companies analyze effective practices in the industry. It also analyzes the major challenges faced by the healthcare ecosystem and its components. The report will also provide ESG-related case studies and a general industry overview. ESG trends and implementation strategies at regional level will also be provided. The impact of COVID-19 will be considered for ESG implementation across the healthcare industry.
Report Includes:
The report scope includes healthcare equipment and services providers, biotechnology companies, and life sciences tools and services companies. The report excludes the pharmaceutical industry. The report will have a detailed analysis of key opportunities that would help companies analyze effective practices in the industry. It also analyzes the major challenges faced by the healthcare ecosystem and its components. The report will also provide ESG-related case studies and a general industry overview. ESG trends and implementation strategies at regional level will also be provided. The impact of COVID-19 will be considered for ESG implementation across the healthcare industry.
Report Includes:
- An overview of the recent trends and advancements with respect to ESG (Environmental, Social, and Governance) factors in the healthcare industry
- Assessment of market growth opportunities, emerging trends, implementation strategies, and issues and challenges pertaining to the ESG implementation in healthcare sector both at regional and global level
- Up-to-date information pertaining to the ESG-related developments in global healthcare industry and analyses of factors affecting ESG implementation applications in healthcare business
- Review of ESG-related case studies and a general industry overview
- A look at the steps taken towards the ESG sustainability and recommendations for the future of the healthcare ecosystem
- Data corresponding to the ESG adoption level across all the industries in 2021 and 2022
- Discussion of the rising focus of healthcare industry market players’ ESG goals and activities
CHAPTER 1 INTRODUCTION
1.1 What is ESG Compliance?
1.2 Study Goals and Objectives
1.3 Reasons for Doing This Study
1.4 Scope of Report
1.5 Intended Audience
1.6 Information Sources
1.7 Analyst's Credentials
1.8 Related BCC Research Reports
CHAPTER 2 HEALTHCARE INDUSTRY OVERVIEW
2.1 Introduction
2.2 Healthcare Industry Supply Chain
2.3 FDA Acts to Face Medical Device Supply Chain Challenges
2.3.1 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)
2.3.2 Resilient Supply Chain and Shortages Prevention Program (RSCSPP)
2.3.3 Technological Advances in Healthcare Supply Chain
2.4 Healthcare Industry: ESG Trends
2.4.1 Impact of COVID-19 and Ukraine Crisis on ESG Trends in Healthcare
2.4.2 Increasing Adoption of ESG Across Various Industries
2.4.3 Advantages of the Implementation of ESG
CHAPTER 3 HEALTHCARE INDUSTRY AND ENVIRONMENTAL IMPACT
3.1 Environmental Footprint of the Healthcare Industry
3.2 Climate Change
3.2.1 Impact of Climate Change on Human Health
3.2.2 Sources of Healthcare Climate Footprint
3.3 Greenhouse Gas Emissions
3.3.1 Greenhouse Gas Protocol Scopes 1, 2, and
3.3.2 Growing Focus on Scope 3 Emissions
3.3.3 NHS to Deliver Net Zero Health Service by 2040
3.4 Potential Impact of Health Sector Actions in Reducing Emissions
3.5 Government Support for Healthcare Sector to Achieve ESG Goals
3.6 Resources to Support Measurement and Action toward Decarbonization
3.7 Biomedical Waste
3.8 Recommendations
CHAPTER 4 HEALTHCARE INDUSTRY AND SOCIAL IMPACT
4.1 Introduction
4.2 Impact of COVID-19 on Healthcare Workforce
4.3 Social Factors in Healthcare Industry
4.3.1 Inclusion, Diversity and Equity
4.3.2 Supporting Global Workforce
4.3.3 Patient Safety and Product Quality
4.3.4 Data Privacy and Security
4.3.5 Supply Chain Responsibility
4.4 Recommendations
CHAPTER 5 HEALTHCARE INDUSTRY AND GOVERNANCE IMPACT
5.1 Introduction
5.2 Existing Issues Pertaining to Healthcare Governance
5.3 Components of Healthcare Governance
5.3.1 Factors in Assessing Governance Disclosure in Hospitals
5.4 Recommendations
CHAPTER 6 MARKET DYNAMICS OF ESG IN HEALTHCARE
6.1 Introduction
6.2 Market Drivers
6.2.1 Growing Investments in ESG Strategies
6.2.2 Increasing Awareness Regarding ESG in Public
6.3 Market Challenges
6.3.1 Lack of Standard Framework
6.3.2 Lack of Consistency in Implementation
6.4 Market Opportunities
6.4.1 Climate Change
6.4.2 Launch of Favorable Initiatives and Measures
CHAPTER 7 ESG ACTIVITIES AMONG PLAYERS IN THE HEALTHCARE MARKET
1.1 What is ESG Compliance?
1.2 Study Goals and Objectives
1.3 Reasons for Doing This Study
1.4 Scope of Report
1.5 Intended Audience
1.6 Information Sources
1.7 Analyst's Credentials
1.8 Related BCC Research Reports
CHAPTER 2 HEALTHCARE INDUSTRY OVERVIEW
2.1 Introduction
2.2 Healthcare Industry Supply Chain
2.3 FDA Acts to Face Medical Device Supply Chain Challenges
2.3.1 Coronavirus Aid, Relief, and Economic Security Act (CARES Act)
2.3.2 Resilient Supply Chain and Shortages Prevention Program (RSCSPP)
2.3.3 Technological Advances in Healthcare Supply Chain
2.4 Healthcare Industry: ESG Trends
2.4.1 Impact of COVID-19 and Ukraine Crisis on ESG Trends in Healthcare
2.4.2 Increasing Adoption of ESG Across Various Industries
2.4.3 Advantages of the Implementation of ESG
CHAPTER 3 HEALTHCARE INDUSTRY AND ENVIRONMENTAL IMPACT
3.1 Environmental Footprint of the Healthcare Industry
3.2 Climate Change
3.2.1 Impact of Climate Change on Human Health
3.2.2 Sources of Healthcare Climate Footprint
3.3 Greenhouse Gas Emissions
3.3.1 Greenhouse Gas Protocol Scopes 1, 2, and
3.3.2 Growing Focus on Scope 3 Emissions
3.3.3 NHS to Deliver Net Zero Health Service by 2040
3.4 Potential Impact of Health Sector Actions in Reducing Emissions
3.5 Government Support for Healthcare Sector to Achieve ESG Goals
3.6 Resources to Support Measurement and Action toward Decarbonization
3.7 Biomedical Waste
3.8 Recommendations
CHAPTER 4 HEALTHCARE INDUSTRY AND SOCIAL IMPACT
4.1 Introduction
4.2 Impact of COVID-19 on Healthcare Workforce
4.3 Social Factors in Healthcare Industry
4.3.1 Inclusion, Diversity and Equity
4.3.2 Supporting Global Workforce
4.3.3 Patient Safety and Product Quality
4.3.4 Data Privacy and Security
4.3.5 Supply Chain Responsibility
4.4 Recommendations
CHAPTER 5 HEALTHCARE INDUSTRY AND GOVERNANCE IMPACT
5.1 Introduction
5.2 Existing Issues Pertaining to Healthcare Governance
5.3 Components of Healthcare Governance
5.3.1 Factors in Assessing Governance Disclosure in Hospitals
5.4 Recommendations
CHAPTER 6 MARKET DYNAMICS OF ESG IN HEALTHCARE
6.1 Introduction
6.2 Market Drivers
6.2.1 Growing Investments in ESG Strategies
6.2.2 Increasing Awareness Regarding ESG in Public
6.3 Market Challenges
6.3.1 Lack of Standard Framework
6.3.2 Lack of Consistency in Implementation
6.4 Market Opportunities
6.4.1 Climate Change
6.4.2 Launch of Favorable Initiatives and Measures
CHAPTER 7 ESG ACTIVITIES AMONG PLAYERS IN THE HEALTHCARE MARKET
LIST OF TABLES
Table 1: Clinical Activity-Based GHG Emission, by Emission Category, 2019
Table 2: Potential Carbon Emissions Savings, by 2050
Table 3: Key Resources to Help Achieve Decarbonization
Table 4: Directives for Developing Healthcare Sustainability Metrics
Table 5: Social Factors in the Healthcare Industry
Table 6: Governance Factors in the Healthcare Industry
Table 7: Net-Zero GHG Commitments, by Major Life Sciences Companies
Table 1: Clinical Activity-Based GHG Emission, by Emission Category, 2019
Table 2: Potential Carbon Emissions Savings, by 2050
Table 3: Key Resources to Help Achieve Decarbonization
Table 4: Directives for Developing Healthcare Sustainability Metrics
Table 5: Social Factors in the Healthcare Industry
Table 6: Governance Factors in the Healthcare Industry
Table 7: Net-Zero GHG Commitments, by Major Life Sciences Companies
LIST OF FIGURES
Figure 1: Healthcare Industry: Classification
Figure 2: Major Segments of the Medical Device Industry
Figure 3: Leading Medical Device Companies, by Revenue, 2021
Figure 4: Leading Biotechnology Companies, by Revenue, as of December 2022
Figure 5: ESG Disclosure Standards for Biotechnology Companies
Figure 6: Distribution of Biotechnology Companies Providing ESG Disclosure, 2022
Figure 7: Healthcare Industry Supply Chain
Figure 8: Healthcare Supply Chain Management Technologies
Figure 9: Snapshot: Key ESG Trends in Healthcare Industry
Figure 10: Level of Adoption of ESG Across All the Industries, Global, 2021 and 2022
Figure 11: Level of Adoption of ESG Across All the Industries, by Region, 2021 and 2022
Figure 12: Environmental Footprint of the Healthcare Industry
Figure 13: Impact of Climate Change on Human Health
Figure 14: Healthcare Industry Projected GHG Footprint per Year, 2014-2050
Figure 15: Greenhouse Gases Accounting Standards, by Scope
Figure 16: Sources of Carbon Emissions, by Proportion of NHS Carbon Footprint Plus
Figure 17: Gender Pay Gap in the Medical Industry, Britain
Figure 18: Components of Healthcare Governance
Figure 19: Governance Factors in Hospitals
Figure 20: ESG in Healthcare: Market Dynamics
Figure 21: List of Healthcare Organizations in the U.S. in 2050 Pledge Timeline
Figure 1: Healthcare Industry: Classification
Figure 2: Major Segments of the Medical Device Industry
Figure 3: Leading Medical Device Companies, by Revenue, 2021
Figure 4: Leading Biotechnology Companies, by Revenue, as of December 2022
Figure 5: ESG Disclosure Standards for Biotechnology Companies
Figure 6: Distribution of Biotechnology Companies Providing ESG Disclosure, 2022
Figure 7: Healthcare Industry Supply Chain
Figure 8: Healthcare Supply Chain Management Technologies
Figure 9: Snapshot: Key ESG Trends in Healthcare Industry
Figure 10: Level of Adoption of ESG Across All the Industries, Global, 2021 and 2022
Figure 11: Level of Adoption of ESG Across All the Industries, by Region, 2021 and 2022
Figure 12: Environmental Footprint of the Healthcare Industry
Figure 13: Impact of Climate Change on Human Health
Figure 14: Healthcare Industry Projected GHG Footprint per Year, 2014-2050
Figure 15: Greenhouse Gases Accounting Standards, by Scope
Figure 16: Sources of Carbon Emissions, by Proportion of NHS Carbon Footprint Plus
Figure 17: Gender Pay Gap in the Medical Industry, Britain
Figure 18: Components of Healthcare Governance
Figure 19: Governance Factors in Hospitals
Figure 20: ESG in Healthcare: Market Dynamics
Figure 21: List of Healthcare Organizations in the U.S. in 2050 Pledge Timeline
